Read the latest developments from our ON Helix 2024 speaker faculty organisations, and prepare for the conference discussions:

Funding Success Stories
Harness Therapeutics raises £4m funding to advance potential Huntingdon’s treatment

Monument Therapeutics accesses £1.5m for schizophrenia clinical development

Research Grant Awards
Ikarovec awarded grant by Innovate UK to develop new wet AMD gene therapy

Prestigious Awards
Owlstone Medical wins $6.5m from Gates Foundation

Ambitious Growth Plans
Astrazeneca sets revenue target at $80B by 2030

Market Leadership
Eli Lilly strengthens position in the obesity drug market

Strategic Acquisitions
MSD to Acquire EyeBio

Clinical Development Milestones
Resolution Therapeutics Announces New Breakthrough Clinical Data for Macrophage Cell Therapy in End Stage Liver Disease at EASL 2024

Strategic Partnerships
Impilo invests in Pelago Bioscience – a fast-growing drug discovery research partner